The hippocampus has long been associated with learning, memory, and modulation of emotional responses. Previous studies demonstrated that stress-induced loss of hippocampal neurons may contribute to the pathogenesis of depression. The recent observations supported that antidepressant drugs increase the production of serotoninergic neurotransmitter and they play a critical role in the initiation of neurogenesis in the hippocampus. In order to explore the possible new mechanism of the treatment of depression, we cultured neural stem cells (NSCs) derived from the hippocampus of adult rats as an in vitro model to evaluate the capabilities of neuroprotection and neural differentiation in NSCs by fluoxetine (FL) treatment. Our results showed that 20 μM FL treatment can significantly increase the proliferation rate of NSCs (p<0.05), and up-regulate the mRNA and protein expressions of Bcl-2 in Day-7 FL-treated NSCs (p<0.01). Using Bcl-2 gene silencing with small interfering RNA, our data verified that FL can prevent Fas ligand-induced caspasedependent apoptosis in NSCs through the activation of Bcl-2. The in vitro observation and immunofluorescent study further demonstrated that FL treatment can stimulate the neurite development and serotoninergic differentiation of NSCs through the activation of Bcl-2. Using microdialysis with high performance liquid chromatography-electrochemical detection, the functional release of serotonin in the differentiating NSCs with FL treatment was increased and simultaneously regulated by the Bcl-2 expressions. In sum, the study results indicate that antidepressant administration can increase NSCs survival, promote the neurite development, and facilitate NSCs differentiating into the functional serotoninergic neurons via the modulation of Bcl-2 expression.
INTRODUCTION
Depression is one of the most common psychiatric disorders, with 10% to 20% lifetime prevalence Gurvits et al., 1996) . However, the pathophysiology and underlying mechanisms of depression still remain unclear. Preclinical and clinical findings have shown that hippocampal volume in patients with depression is reduced in comparison to the volume in healthy people (Sapolsky, 1996) . MRI imaging studies also showed that the hippocampal volume decreases in patients with depression and posttraumatic stress disorder (Gurvits et al., 1996; Sapolsky, 1996) . Some recent studies have demonstrated that increased cell proliferation and neuron numbers in the hippocampus by the administration of antidepressant agents could result in altered behavior in the stress-induced models and patients (Santarelli et al., 2003) . Based on these findings, a novel theory of depression treatment has been proposed. That is, the regulation of neurogenesis in adult brain is a target for the action of antidepressant drugs (Malberg et al., 2000) . Fluoxetine (FL) is a popular antidepressant drugs. Its primary action is based on the inhibition of serotoninreuptake in the central nervous system (CNS). It has been proved to be safe and effective in the treatment of depression as well as other psychiatric and neurodegenerative diseases (Cipriani et al., 2005) . Manev et al. further reported that FL can increase cell proliferation in the hippocampus of adult rats in vivo and in primary neural culture in vitro (Manev et al., 2001) . Maragnoli et al. also demonstrated that FL and olanzapine have synergistic effects on the modulation of fibroblast growth factor 2 expression in the prefrontal cortex, hippocampus, and striatum of a rat brain (Maragnoli et al., 2004) . Moreover, the recent studies showed that the treatment of antidepressant drugs can promote the Bcl-2 expression and increase neuron survival in hippocampus of depressant animals (Manji 2000) . However, whether FL can promote the mechanisms of neuronal proliferation, neuroprotection, and differentiation ability in the hippocampus of CNS has not been elucidated.
Neural stem cells (NSCs), derived from the hippocampus and other germinal centers of the brain, have been isolated and defined as cells with the capacity of self-renewal and mutli-lineage differentiation (Gage, 2000; Goldman, 2005) . NSCs possess the utilizing potential to develop the transplantation strategies and to screen the candidate agents for neu-rogenesis, neuroprotection, and neuroplasticity in neurodegenerative diseases (Goldman, 2005; Chiou et al., 2006) . In order to further elucidate the role of FL in the neural progenitor cell survival, neuroprotection, and specific-lineage neural differentiation, we cultured NSCs derived from the hippocampal tissues of adult rats as a model for in vitro drug-effect test by using the isolation techniques in this study.
Moreover, the previous study demonstrated that NSCs constitutively express the Fas/Fas ligand (FasL) system and Fas (CD95) receptor on cell membranes, providing a physiological model for the study of Fas-dependent apoptosis (Semont et al., 2005) . Recent data suggested the potential role of Fas death receptor-mediated apoptosis in the pathophysiology of adult motor neurons apoptosis and axonal degeneration in spinal cord injury Casha et al., 2005) . Jayanthi et al. further demonstrated that methamphetamine cause neurodegenerative effects and caspasedependent neuronal apoptosis through stimulation of the Fasmediated death pathway (Jayanthi et al., 2005) . In the present study, therefore, we attempted to investigate the role of fluoxetine in anti-FasL-induced apoptosis and neuroprotection, and the caspase-related apoptotic markers (annexin V, caspase 8, caspase 3, DNA fragmentation) were evaluated in FasL-treated NSCs with or without FL treatment. Furthermore, Bcl-2, an anti-apoptotic gene, is a target for the actions of mood stabilizers and mediates many of beneficial effects of endogenous neurotrophic factors (Manji 2000; Bachmann et al., 2005) . Hence, by using Bcl-2 gene silencing with small interfering RNA (siRNA), the aims of the current study are further to investigate the biological cytoprotection effects, the serotoninergic differentiation capability of FL on the NSCs, and to explore the associated mechanisms.
MATERIALS AND METHODS

The Isolation and Culture of Neural Stem Cells (NSCs)
All animals used were treated in accordance with Animal Care and Use Committee guideline at Taipei Veterans General Hospital. The protocol of present study was also approved by the committee. Adult Sprague-Dawley (SD) rats (8 weeks old, 250 g) were anesthetized with intraperitoneal phenobarbital (Sigma, USA), and the location of their brains was mapped. Then, the brain was surgically separated from the hippocampus region with the procedure described by Chiou et al. (Chiou et al., 2006) . In brief, tissues from the hippocampus of adult rats were dissociated and incubated in Hank's balanced salt solution (HBSS) containing collagenase (78 units/ml) and hyaluronidase (38 units/ml) for 10 mins at 37 . The tissues were then mechanically dissected and placed in a trypsin solution (1.33 mg/ml) at 37°C for another 10 mins. Dissociated cells were then centrifuged at 150 G for 5 mins. Then the enzyme solution was removed and replaced with serum-free culture media composed of Dulbecco modified Eagle medium (DMEM) and F-12 nutrient (1:1) including insulin (25 g/mL), transferrin (100 g/mL), progesterone (20 nM), putrescine (60 M), sodium selenite (30 nM), human recombinant epidermal growth factor (EGF) 20 ng/mL, and fibroblast growth factor-basic (bFGF) 20 ng/mL (R&D Systems, Minneapolis, MN). Viable cells were counted by trypan blue exclusion and plated as 5000 cells/200 L per well in 96-well plates (Corning, Acton, MA) with no substrate pretreatment (Chiou et al., 2006) . Fluoxetine (FL) was purchased from Sigma Chem (USA). The 0.1% DMSO (Sigma, USA) was used as a vehicle control in all procedure and studies. About the differentiation protocol, the neurospheres NSCs were plated on poly-L-ornithine-coated (15 g/mL) glass coverslips in individual wells of 24-well plates (1.0 mL/well) in DMEM/F-12 medium containing 2% fetal calf serum (FCS; Gibcol) and withdrawing EGF and bFGF. At the time of NSCs seeding, vehicle control or FL treatment was concurrently added.
Cell Viability Assay
Neural stem cells (NSCs) were seeded on 24-well plates at a density of 2 10 4 cells/well in medium, followed by methyl thiazol tetrazolium assay (MTT assay; Sigma-Aldrich Co.). NSCs were incubated with 0.25 mg/ml MTT for 4 hours at 37 °C and the reaction was terminated by the addition of 100% isopropanol. The amount of MTT formazon product was determined by using a microplate reader and the absorbance was measured at 560 nm (SpectraMax 250, Molecular Devices, Sunnyvale, CA, USA). The NSCs were exposed to 0, 1, 10, 20, 30, 40, 50, 100, 200 , and 300 μM of FL for 1, 3, 5, and 7 days, respectively. The preliminary experiment data showed that the cell proliferation was significantly increased in 20 μM FL-treated NSC cells at Day 3, Day 5 and Day 7 cultures. Since FL at 20 μM was shown to increase cell survival, the concentration of 20 μM FL was chosen for all further experiments.
Real-Time Reverse Transcription-polymerase Chain Reaction (RT-PCR)
For real-time RT-PCR, the total RNA was extracted using the RNA easy kit (Qiagen, Valencia, CA, USA) as previously described (Kao et al., 2005) . Briefly, total RNA (1 μg) of each sample was reversely transcribed in 20 μL using 0.5 μg of oligo dT and 200 U Superscript II RT (Invitrogen, Carlsbad, CA, USA). The amplification was carried out in a total volume of 20 l containing 0.5 M of each primer, 4 mM MgCl 2 , 2 l LightCycler TM -FastStart DNA Master SYBR green I (Roche Molecular Systems, Alameda, CA, USA) and 2 l of 1:10 diluted cDNA. The quantification in the unknown samples was performed by the LightCycler Relative Quantification Software version 3.3 (Roche Molecular Systems, Alameda, CA, USA). In each experiment, the GAPDH housekeeping gene was amplified as a reference standard. GAPDH primers were designed: GAPDH(f): GGGCCAAAAGGGTCATCATC (nt 414-434, GenBank accession no. BC059110. MAP2(r): TCGGTAAGAAAGCCAGTGTG GT (nt 551-573). Nestin (f): TGGAGCGGGAGTTAGAGGCT (nt 525-545, GenBank accession no. NM_012987.1), Nestin (r): ACCTCTAAGCGACACTCCCGA (nt 784-805). Reactions were prepared in duplicate and heated to 95 for 10 mins followed by 40 cycles of denaturation at 95 for 10 seconds, annealing at 55 for 5 seconds, and extension at 72 for 20 seconds. All PCR reactions were performed in duplicate. Standard curves (cycle threshold values versus template concentration) were prepared for each target gene and for the endogenous reference (GAPDH) in each sample. To confirm the specificity of the PCR reaction, PCR products were electrophoresed on a 1.2 % agrose gel.
Immunoblot Analysis
After the treatment with FL, the cell lysates of NSCs were collected and the concentration of protein was determined by using the Protein Assay kit (Bio-Rad, Hercules, CA, USA). Cell extracts with sample buffer were boiled for 5 minutes and then separated by 10 % SDS-PAGE gel. After electrophoresis, the gel was transferred onto a PVDF membrane for immunoblotting. The membrane was first blocked by incubation in non-fat milk at room temperature for 2 hours, then incubated with anti-Bcl-2 antibody (Upstate Biotechnology, Waltham, MA, USA), and anti-actin (Chemicon International, Temecula, CA, USA) for 2 hours at room temperature, washed for five times by Tris-Buffered Saline Tween-20, and then incubated further at room temperature with horseradish peroxidase-conjugated secondary antibody for 2 hours. Then the membrane was washed six times by TBST and specific bands were made visible by chemiluminescence (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Bcl-2 RNA Interference
Double-stranded, short interfering RNA (siRNA) of the Bcl-2 were chemically synthesized by Ambion Inc. (Austin, TX, USA) and the sense and antisense sequences were designed as follows: Sense, GCGCUGGAUAUAACUUCU Utt; Antisense, AAGAAGUUAUAUCCAG C GCtt, starting from nucleotide 137 of Bcl-2 sequence (accession number L14680). In this study, the siRNA control was used siRNACy3 (QIAGEN; sense sequence: UUCUCCGAACGUGU CACGUdTdT-3'-Cy3 and the complement 5'-ACGUGACA CGUU CGGAGAAdTdT-3'-Cy3) as an irrelevant control. The transfection of siRNA was performed using Lipofectamine 2000 (Invitrogen) according to the manufacture's instructions. In brief, cells were harvested with 0.25% trypsin, 1 mM EDTA in phosphate buffered saline (PBS) without Ca 2+ and Mg
2+
, and plated in six-well plates at 10 5 per cm 2 . Then 3.5 μl siRNA (100 μM solution) was mixed with 125 μl serum-free culture medium for 5 min at room temperature. During this incubation period, 5 μl of Lipofectamine 2000 was diluted in 125 μl serum-free culture medium. These two mixtures were combined, mixed gently, and incubated for 20 minutes at room temperature for complex formation. This 250 μl of siRNA-Lipofectamine mixture was then added into the cells in a final volume of 2.5 ml per well. The transfected cells were cultured and fed daily with fresh medium until they were assayed.
Enzyme-Linked Immunosorbent Assay (ELISA) and Terminal dUTP Nick-End Labeling (TUNEL) Assay
The activities of caspases 8 and 3 were determined by ELISA kit (Medical & Biological Laboratories Co., Ltd., Nagoya, Japan) and quantified by reading at A490 nm (MRX; Dynatech Laboratories, Chantilly, VA). Each individual sample was analyzed in triplicate. Furthermore, apoptotic cells were identified by the TUNEL method (In Situ Cell Death Detection Kit, POD, Roche Boehringer Mannheim Corp., IN, USA) as described in Chiou et al. (Chiou et al., 2001) . Briefly, the cells with cover slips were washed with 1X phosphate buffered saline (PBS), fixed with 4% of paraformaldehyde for 10 mins, permeabilized with 0.1 % of triton X-100 for 5 mins, and incubated with the TUNEL reagent provided for 1 hour. Chromogenic development was then applied with 3-amino-9-ethyl-carbazole, and slides were counterstained with H & E stain. The percentage of TUNELpositive cells was measured by the average of the 6 different areas as compared to the total cell number in the same section slide (under x200 power field of light microscope).
Immunofluorescence Staining
An avidin-biotin complex method was used for the immunohistochemical staining in the differentiated NSCs (Chiou et al., 2001) . Following washes with the 3% hydrogen peroxide, sodium azide and antigenicities were retrieved using a microwave. Each slide was then treated with antibodies for Bcl-2 (Upstate Biotechnology, Waltham, MA, USA), MAP2 (Chemicon, Temecula, CA, USA), and serotonin (Chemicon, Temecula, CA, USA). Immunoreactive signals were detected with a mixture of biotinylated rabbit antimouse IgG and Fluoesave (Calbiochem, La Jolla, CA, USA) under the confocal microscopy (Olympus, FV300).
Microdialysis and High Performance Liquid Chromatography-Electrochemical Detection (HPLC-ED)
The microdialysis sampling system containing the Petri dish was constructed in our own laboratory according to the design originally described by Cheng et al. (Cheng et al., 2000) . The dialysis probe was made of a dialysis membrane with 30mm in length, 150 μm in the outer diameter, and a nominal molecular weight cut-off of 13000. Ringer solution (8.6 g/l NaCl, 0.3 g/l KCl and 0.33 g/l CaCl 2 ) was perfused through the probe at a flow-rate of 2 μl/min. Samples of microdialysate were collected every 10 mins. A Model HTEC-500 HPLC-ED system (Eicom, Kyoto, Japan) consisting of three-electrode cell with an Ag/AgCl as the reference electrode, a counter electrode and a graphite electrode as the working electrode were used to determine the levels of 5-HT. The graphite working electrode with a 25 μm gasket and the applied potential was set at +450 mV vs Ag/AgCl. The column used for separation was a PP-ODS (4.6 x 30 mm) (Eicom, Japan) at room temperature (25 o C). The mobile phase, containing 0.1 M sodium phosphate buffer (0.1 M NaH 2 PO 4 : 0.1 M Na 2 HPO 4 = 1000:160, v/v), 1% methanol, 500 mg/l sodium sulfonate and 50 mg/l EDTA, was adjusted to pH 6.0 with 5 M of NaOH with a flow rate of 0.5 ml/min. Each microdialysate of 10 μl was injected manually into the chromatographic system and assayed on the same sampling day.
Statistical Analysis
The results were reported as mean ± SD. Statistical analysis was performed by using the one-way or two-way ANOVA test followed by Tukey's test, or by Student's-t test, as appropriate. A p<0.05 was considered to be statistically significant.
RESULTS
Fluoxetine (FL) Modulates the Cell Viability of Neural Stem Cells (NSCs)
Tissues from the hippocampus region of adult SD rats were dissociated and cultured in the DMEM/F-12 serum-free medium with EGF and bFGF (Chiou et al., 2006) . After being cultured for 1 week, neural stem cells (NSCs) aggregated and formed the spheroid-like bodies called neurosphere (Fig.  1A) . To investigate the neuron-lineage differentiation, the neuropheres were further cultured in the induction medium with 2% fetal bovine serum (FBS) for 14 days, and then gradually differentiated into neural-like cells (Fig. 1B and  1C) . By using the immunofluorescent assay, the percentages of microtubular associated protein-2-positive neurons (MAP-2: neuron marker, arrows; 4', 6-diamidino-2-phenylindole (DAPI): cell nuclei, arrowheads, Fig. 1D ) were 39.3 ± 6.0% and detected in the differentiated NSCs. Furthermore, the cell viability and proliferation of NSCs were analyzed by using the MTT assay. The NSCs were exposed to 0, 1, 10, 20, 30, 40, 50, 100, 200 , and 300 μM of FL for 1, 3, 5, and 7 days, respectively (Fig. 2) . Our data showed that the cell proliferation was significantly increased in 20 μM FL-treated NSC cells at Day 3, Day 5 and Day 7 cultures (p<0.05). Since FL at 20 μM was shown to increase cell survival (Fig.  2) , the concentration of 20 μM FL was chosen for all further experiments.
Detection of Bcl-2 Expression in Fluoxetine (FL)-Treated Neural Stem Cells (NSCs) by Real-time RT-PCR and Western Blot
To evaluate the role of FL on the gene expression of NSCs, mRNA expressions of Bcl-2, Bcl-xL, Bax, Bad, Fas, MAP2, and Nestin were detected in Day 3, Day 5, and Day 7. By using real time RT-PCR method, the results showed that mRNA levels of Bcl-2, Bcl-xL, and Nestin in Day 5 and Day 7 FL-treated NSCs were significantly increased as compared to non FL-treated NSCs (p<0.05; Fig. 3A) . However, the expressions of Bax, Bad, and Fas were not activated in Day 3, Day 5, and Day 7 of FL-treated NSCs (Fig. 3A) . Furthermore, as compared to Day 7 non-FL-treated NSCs, the levels of Bcl-2 mRNA were significantly increased in 1, 10, and 20 μM Day 7 FL-treated NSC groups with a dosedependent manner (Fig. 3B) . By using the western blot method, the protein expressions of Bcl-2 in Day 3 FL-treated NSCs was higher than that in Day 3 non-FL-treated NSCs (as a control; p<0.05; Fig. 4A and 4B) . As shown in Fig.  (4B) , the expression levels of Bcl-2 protein were significantly increased in the Day 7 FL-treated NSCs as compared to Day 3 or Day 5 FL-treated NSCs (p<0.05). Moreover, the results of immunofluorescent study with confocal microscopic survey clearly indicated that the protein of Bcl-2 (arrows; Fig. 4C ) were accumulated and localized in the cytoplasma of Day 7 FL-treated NSCs (Fig. 4C) but not in Day 7 non-FL-treated NSCs (Fig. 4D) .
Detection of the Anti-Apoptotic Activity in Fluoxetine (FL)-Treated Neural Stem Cells (NSCs) by Caspase ELISA and TUNEL Assay
Our real-time RT-PCR results demonstrated that the RNA level of Fas was stably expressed in Day 3, Day 5, and Day 7 FL-treated NSCs. We further investigated whether the up-regulation of Bcl-2 induced by FL would increase or lessen Fas-dependent apoptosis in FL-treated NSCs. The study of FasL-inducing apoptosis was conducted, and the recombinant protein of FasL (200 ng/ml; Upstate Biotechnology; NY, USA) was then added into FL-treated NSCs culture for 48 hours. Under the exposed condition of FasL recombinant protein, our data suggested that the apoptotic activities of annexin V (early apoptotic marker), caspases 8, and caspase 3 in FL-treated NSCs group were significantly decreased than those in non-FL-treated group (p<0.05; Fig.  5A , 5B, and 5C). However, there was no significantly statistic difference between only FL-treated NSCs group and non-FL-treated (control) group (p>0.05; Fig. 5A , 5B, and 5C; Fig. 6A) . Our results also demonstrated that the apoptotic activities in Fas ligand-treated NSCs could be specifically inhibited by the treatment of Z-VAD-FMK (a pan-caspase inhibitor, 40 μM; Fig. 5A-C) . Furthermore, consistent with the caspases 8 and 3 data, the results of TUNEL assay suggested that the treatment of FL could protect FasL-induced apoptosis in FL-treated NSCs (Fig. 6A and 6C) , but not in non-FL-treated NSCs (Fig. 6A and 6B) .
To further investigate the anti-apoptotic function of Bcl-2 in FL-treated NSCs, Bcl-2 siRNA and siRNA controlsiRNA-Cy3 (QIAGEN) were transfected into NSCs 6 hours before FasL treatment. Consistently with the results of annexin V, caspases 8, caspase 3, and TUNEL assays (Fig. 5A-C, 6A, and 6D) , the treatment of Bcl-2 siRNA could significantly increase the apoptotic activities in combination with Fas ligand-and FL-treated NSCs. In contrast to the inhibition effect of Bcl-2 siRNA, the apoptosis activities in siRNA control-transfected groups were dramatically lower than those in Bcl-2 siRNA-transfected groups (Fig. 5A-C, 6A , and 6E). These results confirmed that FL prevents FasLinducing caspase-dependent apoptosis in NSCs through the activation of Bcl-2. 
Bcl-2 Regulates the Neurite Development and Neurite Expansion Induced by Fluoxetine (FL)
To investigate the roles of FL in the neuronal differentiation of NSCs, NSCs were seeded on the polyornithinecoating plates with 2% FBS (Fig. 7A) . We observed the morphological development (the number of neurite, the total of neurite length, and primary dendrites) of neurons over a period of 14 days in NSCs. As shown in Fig. (7B) , FLtreated NSCs projected the neurite and differentiated into the dendritic formation with long process. Moreover, the number of neurite, the total of neurite length, and the primary dendrites in Day 5, Day 7, and Day 14 FL-treated NSCs were significantly increased than those in non-FL-treated NSCs (p<0.05; Fig. 7G, 7H, and 7I) .
To further test whether the FL-stimulated neurite growth is regulated by Bcl-2, we examined the effect of Bcl-2 siRNA on FL-treated NSCs (Fig. 7C and 7D) . Our data showed that the transfection of Bcl-2 siRNA can specifically inhibit the neurite development of FL-treated and non-FLtreated NSCs (Fig. 7C, 7D, 7G, 7H, and 7I) . However, comparing to only FL-treated NSCs, the transfection of siRNA control did not exhibit the significant change of neurite development in FL-treated NSCs (Fig. 7E, and 7F) . Thus, our data supported that the expression of Bcl-2 plays a critical role in the neurite developments of FL-treated NSCs.
Detection of Serotonin (5-HT) Concentration Released from the Fluoxetine (FL)-Treated Neural Stem Cells (NSCs) by High Performance Liquid Chromatographyelectrochemical Detection (HPLC-ED)
To further determine whether FL can promote NSCs differentiation into serotoninergic neurons, the triple-staining immunofluorescent assay was used. The result showed that the fluorescent signals of MAP-2 (neuron marker; arrows; Fig. 8A) , DAPI (nuclei staining; arrowheads; Fig. 8A) , and serotonin (5-HT; arrows; Fig. 8A ) were detected and colocalized in the same differentiated NSCs (merged imaging; Fig. 8A ) after 7 days fluoxetine treatment. The percentages of MAP-2 (38.6±5.9%) and serotonin-positive (33.5±6.2%) cells in the Day 7 culture of FL-treated NSCs were significantly increased compared to the Day 7 non-FL-treated NSCs (MAP-2: 28.9±5.1%; serotonin: 18.2±3.9%), respectively (p<0.05). To further identify the functional production of serotonin (5-HT) in these NSC-derived neurons, the method of microdialysis coupled with HPLC-ED was used to measure the concentration of 5-HT in the medium of FLtreated NSCs (Fig. 8B) . The results showed that 5-HT levels in Day 3, Day 5, Day 7, and Day 14 of the culture mediums of FL-treated NSCs were significantly higher than those NSCs without FL treatment (p<0.05; Fig. 8C ). We also found that the productions of 5-HT in Day 3, Day 5, Day 7, and Day 14 of FL-treated NSCs were significantly inhibited by the transfection of Bcl-2 siRNA (p<0.05; Fig. 8B and  8C) . In contrast to the inhibition effects of Bcl-2 siRNA, the concentrations of 5-HT in siRNA control-treated group were higher than those in Bcl-2 siRNA-treated and non-FL-treated groups (p<0.05; Fig. 8B and 8C) .
DISCUSSION
FL has been reported to have varying effects on increasing cell proliferation, preventing apoptosis in dentate gyrus, stimulating DNA synthesis, and inhibiting UV-induced DNA fragmentation (Wright et al., 1994; Lee et al., 2001) . Kodama et al. further reported that chronic administration of FL increases neurogenesis in the hippocampus, prelimbic cortex, and dentate gyrus of adult rats (Kodama et al., 2004) . By using the in vitro culture of neural stem cells from the hippocampus of adult rats (Fig. 1) , our study demonstrated that the 20 μM concentration of FL could increase the viability and proliferation of NSCs (Fig. 2) . We further found that the proliferation capability and cell viability of NSCs were significantly decreased when the concentration of FL was beyond 100 μM (Fig. 2) . Using TUNEL assay and Bcl-2 gene silencing with siRNA, our data further confirmed that 20 μM FL-treated NSC cells can specifically prevent FasL-induced apoptosis in NSCs through the up-regulation of Bcl-2 expression (Figs. 5 and 6 ). More importantly, by the use of Bcl-2 siRNA and continuous monitoring of 5-HT, we provided the evidence that FL not only promotes neuronal axon development (Fig. 7) , but also facilitates the release of 5-HT via the activation of Bcl-2 (Fig. 8) .
Fas receptor (CD95 or APO1) is well known to interact with cytoplasmic Fas-associated death domain protein (FADD) and, upon Fas ligand (FasL) binding, allows activation of caspase 8 and caspase 3 leading to apoptosis (Siegel et al., 2000) . The recent studies have demonstrated that Fas death receptor-mediated apoptosis plays a critical role in neurodegenerative disorders, adult motor neurons apoptosis, and neuron loss in amyotrophic lateral sclerosis (ALS) through the stimulation of caspase-8 activation and caspasedependent signaling pathway Casha et al., 2005; Jayanthi et al., 2005) . By using FasL-triggering apoptosis in hippocampus-derived NSCs as an in vitro neuraldamage model, our result showed that FL treatment can significantly inhibit the apoptotic activities of annexin V (early apoptotic marker), caspases 8, caspase 3, and DNA fragmentation (TUNEL assay) in FL-treated NSCs (Fig. 5A, 5B, 5C , and 6). The apoptotic activities in Fas ligand-treated NSCs can be specifically inhibited by the treatment of pan-caspase inhibitor (Z-VAD-FMK, 40 μM; Fig. 5A-C, and 6) . These findings confirmed that FL prevents FasL-inducing caspasedependent apoptosis in NSCs. In addition, the elevated Bcl-2 transcription and translation levels in 20 μM FL-treated NSCs were demonstrated by real-time RT-PCR and western blotting assay (Figs. 3 and 4) . Bcl-2, an anti-apoptotic protein, has recently been identified as a neuronal cell death repressor and plays an important role in the protection of neuronal apoptosis caused by chemical damage, hypoxia, and 6-OHDA-induced neuronal toxicity (Myers et al., 1995; Manakova et al., 2004) . In this study, we used Bcl-2 gene silencing with siRNA to induce sequence-specific degradation of Bcl-2 mRNA or inhibit translation of Bcl-2 complementary mRNA in transfected NSCs. As shown in Figs. (5 and 6), the apoptotic activities (annexin V, caspase 8, casepase 3, and TUNEL) were significantly increased in FL/ FasL/Bcl-2 siRNA-treated NSCs compared to FL/FasL-treated-only NSCs. This result indicated that FL increased the anti-apoptotic activity in NSCs through the modulation of Bcl-2 expression. Thus, the neuroprotection function of FLtreated NSCs could attribute to the activation of Bcl-2 and protect FasL-induced caspase-dependent apoptosis in NSCs.
The recent studies demonstrated that the expression of Bcl-2 not only plays a role in the neuroprotection but also is associated with the triggering of the embryonic stem cells differentiating into mature neurons (Rolletschek et al., 2001) . The postmortem brain studies have suggested the possible involvement of Bcl-2 in mood disorders, and the upregulation of Bcl-2 will exert trophic effects, and enhance cellular resilience in the treatment of mood disorders (Bachmann et al., 2005) . Moreover, Bcl-xL, an anti-apoptotic gene, is a member of the Bcl-2 family and can stimulate the differentiation of the embryonic cells of a mouse into both the dopaminergic and serotoninergic neurons (Shim et al., 2004) . Hayley et al. further suggested that the reduction of expression levels of Bcl-2 not only decrease neurogenesis but also impair the process of neuronal branching under depression and chronic stressor exposure (Hayley et al., 2005) . In accordance with these findings, our results showed that FL can up-regulate the mRNA and protein expression of Bcl-2 in NSCs (Fig. 3 and 4) . We also demonstrated that FL increased the neuron differentiation, and promoted neuronal axon development (number of neurite, the total of neurite length, and primary dendrites; Fig. 7) through the modulation of Bcl-2 expression. These observations implicated that FL may play a key role in neural cell proliferation, neurite outgrowth, and certain forms of neural plasticity of CNS.
Serotonin plays an important role in the neurogenic effects, immune modulator, and synaptic plasticity in the adult CNS (Lesch, 2001) . Ou et al. reported that monoamine oxidase (MAO) A can degrade serotonin (5-HT), norepinephrine, and dopamine and involves in apoptotic signaling pathway mediated by caspase 3 (Ou et al., 2006) . Antidepressant drugs may further increase the production of serotonin and promote the abilities of neuroprotection in neural progenitor cells through Bcl-2 and Bcl-xL activation (Ou et al., 2006; Egan, 2006) . In agreement of these findings, our immunofluorescent study firstly demonstrated that FL treatment can significantly increase the percentage of serotonin (5-HT)-positive neurons in the differentiating NSCs (Fig.  8A) . The results of microdialysis and HPLC-ED further showed that the functional-release concentrations of 5-HT in FL-treated NSCs were concomitantly enhanced ( Fig. 8B and 8C). Moreover, the productions of 5-HT in FL-treated NSCs were simultaneously regulated by the Bcl-2 expressions ( Fig.  8B and 8C) . Thus, our results supported that Bcl-2 expression induced by FL can lead to neural stem cell differentiation and promote 5-HT release in hippocampus-derived NSCs.
In conclusion, our results implicate that the up-regulated Bcl-2 expression by antidepressant administration in NSCs play a critical role in neuroprotection, the stimulation of neurite development, neural differentiation, and the functional release of serotonin in NSCs-derived neurons and they are verified by Bcl-2 gene silencing with siRNA. Moreover, our study supports the idea that this in vitro monitoring model can be considered a valuable tool to discover new mechanisms and screen the candidate genes in drug-effect research.
